162 related articles for article (PubMed ID: 2997951)
1. Cytomegalovirus immunity in allogeneic marrow grafting.
Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
3. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
[TBL] [Abstract][Full Text] [Related]
5. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
[TBL] [Abstract][Full Text] [Related]
7. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
Boland GJ; Vlieger AM; Ververs C; De Gast GC
Clin Exp Immunol; 1992 Jun; 88(3):506-11. PubMed ID: 1318805
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
Lutz E; Ward KN; Szydlo R; Goldman JM
J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease.
Gratama JW; Fibbe WE; Naipal AM; Slats J; Stijnen T; D'Amaro J; Bolhuis RL; The TH; Janssen J
Bone Marrow Transplant; 1986 Dec; 1(2):141-6. PubMed ID: 2844332
[TBL] [Abstract][Full Text] [Related]
10. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
De Witte T; Schattenberg A; Van Dijk BA; Galama J; Olthuis H; Van der Meer JW; Kunst VA
Transplantation; 1990 Dec; 50(6):964-8. PubMed ID: 2175059
[TBL] [Abstract][Full Text] [Related]
11. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.
Woo PC; Lo CY; Lo SK; Siau H; Peiris JS; Wong SS; Luk WK; Chan TM; Lim WW; Yuen KY
Clin Diagn Lab Immunol; 1997 Sep; 4(5):515-8. PubMed ID: 9302197
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-leukaemia activity associated with cytomegalovirus seropositive bone marrow donors but separated from graft-versus-host disease in allograft recipients with AML.
Jacobsen N; Lönnqvist B; Ringdén O; Rajantie J; Siimes MA; Volin L; Ruutu T; Nikoskelainen J; Toivanen A; Ryder L
Eur J Haematol; 1987 Apr; 38(4):350-5. PubMed ID: 3038601
[TBL] [Abstract][Full Text] [Related]
13. CMV antigenemia following bone marrow transplantation: risk factors and outcomes.
Osarogiagbon RU; Defor TE; Weisdorf MA; Erice A; Weisdorf DJ
Biol Blood Marrow Transplant; 2000; 6(3):280-8. PubMed ID: 10871153
[TBL] [Abstract][Full Text] [Related]
14. IgG-subclass-specific CMV reactivity in bone marrow transplant recipients.
Wahren B; Linde A; Sundqvist VA; Ljungman P; Lönnqvist B; Ringdén O
Transplantation; 1984 Nov; 38(5):479-83. PubMed ID: 6093297
[TBL] [Abstract][Full Text] [Related]
15. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC
Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833
[TBL] [Abstract][Full Text] [Related]
16. Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients.
Filipovich AH; Peltier MH; Bechtel MK; Dirksen CL; Strauss SA; Englund JA
Blood; 1992 Nov; 80(10):2656-60. PubMed ID: 1330079
[TBL] [Abstract][Full Text] [Related]
17. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
[TBL] [Abstract][Full Text] [Related]
18. Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants.
Humar A; Wood S; Lipton J; Messner H; Meharchand J; McGeer A; MacDonald K; Mazzulli T
Clin Infect Dis; 1998 Mar; 26(3):606-10. PubMed ID: 9524831
[TBL] [Abstract][Full Text] [Related]
19. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
20. Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease.
Gratama JW; Sinnige LG; Weijers TF; Zwaan FE; van Heugten JG; Stijnen T; D'Amaro J; The TH; Hekker AC; de Gast GC
Exp Hematol; 1987 Aug; 15(7):735-40. PubMed ID: 3038583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
